Saltar al contenido
Merck
  • Stress echocardiography to assess stenosis severity and predict outcome in patients with paradoxical low-flow, low-gradient aortic stenosis and preserved LVEF.

Stress echocardiography to assess stenosis severity and predict outcome in patients with paradoxical low-flow, low-gradient aortic stenosis and preserved LVEF.

JACC. Cardiovascular imaging (2013-03-16)
Marie-Annick Clavel, Pierre Vladimir Ennezat, Sylvestre Maréchaux, Jean G Dumesnil, Romain Capoulade, Zeineb Hachicha, Patrick Mathieu, Annaïk Bellouin, Sébastien Bergeron, Patrick Meimoun, Marie Arsenault, Thierry Le Tourneau, Agnès Pasquet, Christian Couture, Philippe Pibarot
RESUMEN

The objective of this study was to examine the value of stress-echocardiography in patients with paradoxical low-flow, low-gradient (PLFLG) aortic stenosis (AS). The projected aortic valve area (AVAProj) at a normal flow rate was calculated in 55 patients with PLFLG AS. In the subset of patients (n = 13) who underwent an aortic valve replacement within 3 months after stress echocardiography, AVA(Proj) correlated better with the valve weight compared to traditional resting and stress echocardiographic parameters of AS severity (AVA(Proj): r = -0.78 vs. other parameters: r = 0.46 to 0.56). In the whole group (N = 55), 18 (33%) patients had an AVA(Proj) >1.0 cm(2), being consistent with the presence of pseudo severe AS. The AVA(Proj) was also superior to traditional parameters of stenosis severity for predicting outcomes (hazard ratio: 1.32/0.1 cm(2) decrease in AVA(Proj)). In patients with PLFLG AS, the measurement of AVA(proj) derived from stress echocardiography is helpful to determine the actual severity of the stenosis and predict risk of adverse events.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Dobutamine hydrochloride, ≥98%
Dobutamine hydrochloride, European Pharmacopoeia (EP) Reference Standard